A pooled analysis of the IL-10-1082 A/G polymorphism and the nasopharyngeal carcinoma susceptibility

被引:4
作者
Ma, Liping [1 ]
Li, Shan [1 ]
Lu, Yu [1 ]
Zhang, Xiaolian [1 ]
Zhao, Jiangyang [1 ]
Qin, Xue [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning 530021, Guangxi, Peoples R China
关键词
IL-10; Polymorphism; NPC; Meta-analysis; INHIBITS CYTOKINE PRODUCTION; EPSTEIN-BARR-VIRUS; PROMOTER POLYMORPHISMS; GENE POLYMORPHISMS; INTERLEUKIN-10; CELL; EXPRESSION; RISK; ASSOCIATION; EPIDEMIOLOGY;
D O I
10.1007/s00405-014-3465-9
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
It has been reported that IL-10-1082 A/G polymorphism might influence the transcription and secretion of IL10 and tumor development. While many studies have been conducted to investigate the association between IL-10-1082 A/G polymorphism and risk of nasopharyngeal carcinoma (NPC) in various populations, the results of these studies are still controversial. We aimed to explore this relationship through a cumulative meta-analysis. A search of the literature was performed using the Cochrane Library, PubMed, and EMBASE databases. The odds ratio (OR) and corresponding 95 % confidence interval (CI) were calculated to assess this possible association. Six studies were included in the study. The meta-analysis reveals a significant effect in the allelic model (G vs. A: OR 1.516, 95 % CI 1.077-2.133, P (heterogeneity) = 0.003), dominant model (AG + GG vs. AA: OR = 1.770, 95 % CI 1.415-2.212, P (heterogeneity) = 0.169), and co-dominant model (AG vs. AA: OR = 1.747, 95 % CI 1.377-2.216, P (heterogeneity) = 0.491). Similarly, in the stratified analyses, significant effects were reported in studies of Asian populations. Our meta-analysis results suggest that the IL-10-1082 A/G variant is associated with increased risk of NPC in Asian populations.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 35 条
[1]   Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma:: comparison with Hodgkin's disease [J].
Beck, A ;
Päzolt, D ;
Grabenbauer, GG ;
Nicholls, JM ;
Herbst, H ;
Young, LS ;
Niedobitek, G .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :145-151
[2]  
Budiani Dyah R., 2002, Journal of Microbiology Immunology and Infection, V35, P265
[3]   EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies [J].
Busson, P ;
Keryer, C ;
Ooka, T ;
Corbex, M .
TRENDS IN MICROBIOLOGY, 2004, 12 (08) :356-360
[4]  
Cao Su-Mei, 2011, Chin J Cancer, V30, P114
[5]   Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10 [J].
Cervenak, L ;
Morbidelli, L ;
Donati, D ;
Donnini, S ;
Kambayashi, T ;
Wilson, JL ;
Axelson, H ;
Castaños-Velez, E ;
Ljunggren, HG ;
Malefyt, RD ;
Granger, HJ ;
Ziche, M ;
Bejarano, MT .
BLOOD, 2000, 96 (07) :2568-2573
[6]   The enigmatic epidemiology of nasopharyngeal carcinoma [J].
Chang, Ellen T. ;
Adami, Hans-Olov .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) :1765-1777
[7]   A case-control study of risk factors of nasopharyngeal carcinoma [J].
Chen, DL ;
Huang, TB .
CANCER LETTERS, 1997, 117 (01) :17-22
[8]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma [J].
Farhat, K. ;
Hassen, E. ;
Gabbouj, S. ;
Bouaouina, N. ;
Chouchane, L. .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (03) :197-205